...
机译:在多巴胺转运蛋白的一系列(双(4-氟苯基)甲基)亚磺基族氨基胺的结构 - 活性关系:官能化末端氮会影响亲和力,选择性和代谢稳定性
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
Univ Copenhagen Fac Hlth &
Med Sci Dept Neurosci &
Pharmacol Mol Neuropharmacol &
Genet Lab DK-2200 Copenhagen Denmark;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
Johns Hopkins Univ Sch Med Dept Neurol Johns Hopkins Drug Discovery 855 North Wolfe St Baltimore MD 21205 USA;
Johns Hopkins Univ Sch Med Dept Neurol Johns Hopkins Drug Discovery 855 North Wolfe St Baltimore MD 21205 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program NIH 333 Cassell Dr Baltimore MD 21224 USA;
机译:在多巴胺转运蛋白的一系列(双(4-氟苯基)甲基)亚磺基族氨基胺的结构 - 活性关系:官能化末端氮会影响亲和力,选择性和代谢稳定性
机译:用于一系列3α-[双(4-氟苯苯基)甲氧基]对象和3α-[双(4-氟苯基)甲基氨基]铁烷作为新型非典型多巴胺转运蛋白(DAT)抑制剂,用于治疗可卡因使用障碍
机译:一系列双(苯基烷基)胺的结构活性关系:N-甲基-D-天冬氨酸受体的有效亚型选择性抑制剂。
机译:一系列3α-双(4-氟苯基)甲氧基托烷和3α-双(4-氟苯基)甲基氨基托烷作为新型非典型多巴胺转运蛋白(DAT)抑制剂的可卡因使用障碍的结构-活性关系研究
机译:多巴胺转运蛋白和σ1受体的双探针:新型哌嗪基烷基 - 双(4'-氟苯基)胺类似物作为潜在的可卡因滥用治疗剂